FDA Inspection 1106577 — Natren Inc.

Natren Inc. — FEI 2024261

The FDA completed an inspection of Natren Inc. on October 8, 2019 in Thousand Oaks, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
October 8, 2019
Fiscal Year
2020
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Thousand Oaks, CA (United States)

Citations

IDCFRDescription
180921 CFR 211.160(a)Following/documenting laboratory controls
357221 CFR 211.100(b)Procedure Deviations Recorded and Justified